NOVADEL PHARMA INC filed this 4 on 04/01/2010.
	Outline	Printer Friendly	First Page »

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Expires: December 31, 2014 Estimated average burden hours per response 0.5
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* Moorin Jay (Last) (First) (Middle) C/O PROQUEST INVESTMENTS, 90 NASSAU STREET, 5TH FLOOR (Street) PRINCETON NJ 08542-4520 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol NOVADEL PHARMA INC [NVDL]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director X 10% Owner Officer (give title below) Other (specify below)
	3. Date of Earliest Transaction (Month/Day/Year) 03/31/2010
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) Form filed by One Reporting Person X Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/31/2010		P		4,848,485	A	$ 0.165 (8)	34,353,138	I	See (1)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code (Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5)

6. Date Exercisable and Expiration Date (Month/Day/Year)

7. Title and Amount of Underlying Securities (Instr. 3 and 4)

8. Price of Derivative Security (Instr. 5)

9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)

10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)

11. Nature of Indirect Beneficial Ownership (Instr. 4)

Code

V

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Warrants to Purchase Common Stock

$ 0.1888

11/25/2005

05/26/2010

Common Stock

1,394,871

1,394,871

I

See (2)

Warrants to Purchase Common Stock

$ 0.1888

10/12/2006

04/12/2011

Common Stock

206,899

206,899

I

See (3)

Warrants to Purchase Common Stock

$ 0.1888

12/27/2006

12/27/2011

Common Stock

384,766

384,766

I

See (4)

Warrants to Purchase Common Stock

$ 0.1888

12/01/2008

05/30/2013

Common Stock

3,000,000

3,000,000

I

See footnote (5)

Warrants to Purchase Common Stock

$ 0.1888

04/17/2009

10/17/2013

Common Stock

6,446,809

6,446,809

I

See footnote (6)

Series A Warrants to Purchase Common Stock

$ 0.25

03/31/2010

P

2,424,243

03/31/2010

03/31/2015

Common Stock

2,424,243

$ 0 (8)

2,424,243

I

See footnote (7)

Series B Warrants to Purchase Common Stock

$ 0.25

03/31/2010

P

1,616,162

03/31/2010

09/30/2010

Common Stock

1,616,162

$ 0 (8)

1,616,162

I

See footnote (7)

1. Name and Address of Reporting Person* Moorin Jay (Last) (First) (Middle) C/O PROQUEST INVESTMENTS, 90 NASSAU STREET, 5TH FLOOR (Street) PRINCETON NJ 08542-4520 (City) (State) (Zip)

1. Name and Address of Reporting Person* SCHREIBER ALAIN (Last) (First) (Middle) C/O PROQUEST INVESTMENTS, 90 NASSAU STREET, 5TH FLOOR (Street) PRINCETON NJ 08542-4520 (City) (State) (Zip)

1. Name and Address of Reporting Person* ProQuest Investments III, L.P. (Last) (First) (Middle) 90 NASSAU STREET, 5TH FLOOR (Street) PRINCETON NJ 08542-4520 (City) (State) (Zip)

1. Name and Address of Reporting Person* ProQuest Associates III LLC (Last) (First) (Middle) 90 NASSAU STREET, 5TH FLOOR (Street) PRINCETON NJ 08542-4520 (City) (State) (Zip)

1. Name and Address of Reporting Person* PROQUEST INVESTMENTS II LP (Last) (First) (Middle) 90 NASSAU STREET, 5TH FLOOR (Street) PRINCETON NJ 08542-4520 (City) (State) (Zip)

1. Name and Address of Reporting Person* PROQUEST INVESTMENTS II ADVISORS FUND LP (Last) (First) (Middle) 90 NASSAU STREET, 5TH FLOOR (Street) PRINCETON NJ 08542-4520 (City) (State) (Zip)

1. Name and Address of Reporting Person* PROQUEST ASSOCIATES II LLC (Last) (First) (Middle) 90 NASSAU STREET, 5TH FLOOR (Street) PRINCETON NJ 08542-4520 (City) (State) (Zip)

Explanation of Responses:

1. Of such total shares: 23,417,138 are owned by ProQuest Investments III, L.P. ("Investments III"), of which ProQuest Associates III LLC ("Associates III") is the general partner; 9,530,152 are owned by ProQuest Investments II, L.P. ("Investments II"), of which ProQuest Associates II LLC ("Associates II") is the general partner; and 143,101 are owned by ProQuest Investments II Advisors Fund, L.P. ("Advisors"), of which Associates II is the general partner. Jay Moorin and Alain Schreiber are managing members of Associates III and Associates II. All of such new shares were acquired by Associates II. Each of the Reporting Persons disclaims beneficial ownership of such securities except to the extent of each Reporting Person's pecuniary interest in such securities.

2. Of such warrants: 1,107,078 are owned by Investments III; 281,030 are owned by Investments II; and 6,763 are owned by Advisors. Each of the Reporting Persons disclaims beneficial ownership of such securities except to the extent of each Reporting Person's pecuniary interest in such securities.

3. Of such warrants: 164,210 are owned by Investments III; 41,684 are owned by Investments II; and 1,005 are owned by Advisors. Each of the Reporting Persons disclaims beneficial ownership of such securities except to the extent of each Reporting Person's pecuniary interest in such securities.

4. Of such warrants: 305,380 are owned by Investments III; 77,520 are owned by Investments II; and 1,866 are owned by Advisors. Each of the reporting persons disclaims beneficial ownership of such securities except to the extent of each Reporting Person's pecuniary interest in such securities.

5. Of such warrants: 2,381,030 are owned by Investments III; 604,419 are owned by Investments II; and 14,551 are owned by Advisors. Each of the Reporting Persons disclaims beneficial ownership of such securities except to the extent of each Reporting Person's pecuniary interest in such securities.

6. Of such warrants: 5,116,683 are owned by Investments III; 1,298,858 are owned by Investments II; and 31,268 are owned by Advisors. Each of the Reporting Persons disclaims beneficial ownership of such securities except to the extent of each Reporting Person's pecuniary interest in such securities.

7. Such warrants are owned by Investments II. Each of the Reporting Persons disclaims beneficial ownership of such securities except to the extent of each Reporting Person's pecuniary interest in such securities.

8. On March 31, 2010, Investments II acquired 4,848,485 shares of Common Stock, Series A Warrants to purchase 2,424,243 shares of Common Stock and Series B Warrants to purchase 1,616,162 shares of Common Stock, all for an aggregate price of $800,000.03.

	Pasquale DeAngelis, as Attorney-in-Fact	04/01/2010
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.